Academic Content and Language Evaluation of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (4072)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Mar 24, 2022 (publication date) through May 16, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Clinical Oncology
ISSN
2218-4333
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Valencia GA, Rioja P, Morante Z, Ruiz R, Fuentes H, Castaneda CA, Vidaurre T, Neciosup S, Gomez HL. Immunotherapy in triple-negative breast cancer: A literature review and new advances. World J Clin Oncol 2022; 13(3): 219-236 [PMID: 35433291 DOI: 10.5306/wjco.v13.i3.219] |
|---|---|
| URL: | https://www.wjgnet.com/2218-4333/full/v13/i3/219.htm |
| Number | Citing Articles |
| 1 |
Madelyn J. Abraham, Christophe Goncalves, Paige McCallum, Vrinda Gupta, Samuel E. J. Preston, Fan Huang, Hsiang Chou, Natascha Gagnon, Nathalie A. Johnson, Wilson H. Miller, Koren K. Mann, Sonia V. del Rincon. Tunable PhenoCycler imaging of the murine pre-clinical tumour microenvironments. Cell & Bioscience 2024; 14(1) doi: 10.1186/s13578-024-01199-4
|
| 2 |
Siena M. Mantooth, Yara Abdou, Ana Rosa Saez-Ibañez, Samik Upadhaya, David A. Zaharoff. Intratumoral delivery of immunotherapy to treat breast cancer: current development in clinical and preclinical studies. Frontiers in Immunology 2024; 15 doi: 10.3389/fimmu.2024.1385484
|
| 3 |
Meghavi Kathpalia, Anurag Sharma, Navkiran Kaur. Sacituzumab Govitecan as a Second-Line Treatment in Relapsed/Refractory Metastatic Triple-Negative Breast Cancer Patients: A Systematic Review and Meta-analysis. Annals of Pharmacotherapy 2024; 58(1): 44 doi: 10.1177/10600280231164110
|
| 4 |
Lakshmi Kumari, Lopamudra Mishra, Preeti Patel, Nitin Sharma, Ghanshyam Das Gupta, Balak Das Kurmi. Emerging targeted therapeutic strategies for the treatment of triple-negative breast cancer. Journal of Drug Targeting 2023; 31(9): 889 doi: 10.1080/1061186X.2023.2245579
|
| 5 |
Jimoh Mutiu Alani, Damilola Quazeem Olaoye, Abdus-Salam Adesina Abass. Adoption and use of immunotherapy in breast cancer management in Africa: barriers and prospect – a narrative review. Annals of Medicine & Surgery 2023; 85(12): 6041 doi: 10.1097/MS9.0000000000001398
|
| 6 |
Julia D. Ransohoff, Victor Ritter, Natasha Purington, Karen Andrade, Summer Han, Mina Liu, Su-Ying Liang, Esther M. John, Scarlett L. Gomez, Melinda L. Telli, Lidia Schapira, Haruka Itakura, George W. Sledge, Ami S. Bhatt, Allison W. Kurian. Antimicrobial exposure is associated with decreased survival in triple-negative breast cancer. Nature Communications 2023; 14(1) doi: 10.1038/s41467-023-37636-0
|
| 7 |
Neha Mehrotra, Kaushik Pal. Tumor targeted nanohybrid for dual stimuli responsive and NIR amplified photothermal/photo-induced thermodynamic/chemodynamic combination therapy. Biomedical Materials 2024; 19(3): 035019 doi: 10.1088/1748-605X/ad330f
|
| 8 |
Reza Mehdizadeh, Seyed Peyman Shariatpanahi, Bahram Goliaei, Curzio Rüegg. Targeting myeloid-derived suppressor cells in combination with tumor cell vaccination predicts anti-tumor immunity and breast cancer dormancy: an in silico experiment. Scientific Reports 2023; 13(1) doi: 10.1038/s41598-023-32554-z
|
| 9 |
Timothy B. Fisher, Geetanjali Saini, T. S. Rekha, Jayashree Krishnamurthy, Shristi Bhattarai, Grace Callagy, Mark Webber, Emiel A. M. Janssen, Jun Kong, Ritu Aneja. Digital image analysis and machine learning-assisted prediction of neoadjuvant chemotherapy response in triple-negative breast cancer. Breast Cancer Research 2024; 26(1) doi: 10.1186/s13058-023-01752-y
|
| 10 |
Md Abdus Subhan, Farzana Parveen, Hassan Shah, Satya Siva Kishan Yalamarty, Janaína Artem Ataide, Valdimir P. Torchilin. Recent Advances with Precision Medicine Treatment for Breast Cancer including Triple-Negative Sub-Type. Cancers 2023; 15(8): 2204 doi: 10.3390/cancers15082204
|
| 11 |
Chun-Ming Chang, Ting-Ruei Liang, Ho Yin Pekkle Lam. The Use of Schisandrin B to Combat Triple-Negative Breast Cancers by Inhibiting NLRP3-Induced Interleukin-1β Production. Biomolecules 2024; 14(1): 74 doi: 10.3390/biom14010074
|
| 12 |
Annat Raiter, Julia Lipovetsky, Asaf Stenbac, Ido Lubin, Rinat Yerushalmi. TNBC-derived Gal3BP/Gal3 complex induces immunosuppression through CD45 receptor. OncoImmunology 2023; 12(1) doi: 10.1080/2162402X.2023.2246322
|
| 13 |
Soon Cheon Shin, Renee E. Vickman, Beniamin Filimon, Yuefeng Yang, Zebin Hu, Kathy A. Mangold, Bellur S. Prabhakar, Hans Schreiber, Weidong Xu. The safety and efficacy of systemic delivery of a new liver-de-targeted TGFβ signaling inhibiting adenovirus in an immunocompetent triple negative mouse mammary tumor model. Cancer Gene Therapy 2024; 31(4): 574 doi: 10.1038/s41417-024-00735-1
|
| 14 |
John Yeh. Breast Cancer and Women’s Health Physicians: Implications for New
Approaches to Diagnosis and Treatment. Current Womens Health Reviews 2024; 20(3) doi: 10.2174/157340482003240213150542
|
| 15 |
Priyanka Hirani, Jacqueline McDermott, Vinothini Rajeeve, Pedro R. Cutillas, J. Louise Jones, Daniel J. Pennington, Thomas N. Wight, Salvatore Santamaria, Kimberly M. Alonge, Oliver M.T. Pearce. Versican Associates with Tumor Immune Phenotype and Limits T-cell Trafficking via Chondroitin Sulfate. Cancer Research Communications 2024; 4(4): 970 doi: 10.1158/2767-9764.CRC-23-0548
|
| 16 |
Eleonora Martinis, Carolina Ricci, Caterina Trevisan, Gaia Tomadini, Silvia Tonon. Cancer Vaccines: From the State of the Art to the Most Promising Frontiers in the Treatment of Colorectal Cancer. Pharmaceutics 2023; 15(7): 1969 doi: 10.3390/pharmaceutics15071969
|